Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-03-03

Clinical Trial Update: Locally Delivered 1% Metformin Gel in the Treatment of Intrabony Defects in Chronic Periodontitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating locally delivered 1% metformin gel for treating intrabony defects in chronic periodontitis; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metformin gel (metformin)

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Intrabony Defects in Chronic Periodontitis | Phase 2 | Status: UNKNOWN